IMUX — IMMUNIC INC

Ownership history in Aberdeen Group plc  ·  4 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in IMMUNIC INC (IMUX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 8,243,941 — 0% 0.01% $4.4M $0.53
2025 Q3 UNCHANGED 8,243,941 — 0% 0.01% $7.3M $0.88
2025 Q2 ADDED 8,243,941 +7,184,457 +678.1% 0.01% $5.8M $0.70
2025 Q1 INITIATED 1,059,484 — — 0.00% $1.2M $1.09
% of Fund (quarterly)    IMUX price (monthly, adj. close)

Other funds also holding IMUX

As of 2025 Q4 — sorted by position size

Avidity Partners Management LP 3Y 0.72% BVF INC/IL 3Y 7Y 0.14% Connective Capital Management, LLC 3Y 7Y 0.09% Nantahala Capital Management, LLC 3Y 7Y 0.08% Laurion Capital Management LP 3Y 7Y 0.06% Seven Fleet Capital Management LP 0.06% Ikarian Capital, LLC 3Y 0.03% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.02% Strategies Wealth Advisors, LLC 0.01% XTX Topco Ltd 3Y 0.0%
← Back to Aberdeen Group plc Holdings